Home > Insider Trading > Filing (0001127602-25-006999)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1835597	Pepgen Inc.	PEPG	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1922546	Noel Donnelly	321 Harrison Ave., 8Th Floor C/O Pepgen Inc. Boston MA 02118	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-02-24	3,200	$0.00	3,200	No	4	A	Direct
Common Stock	Disposition	2025-02-26	1,527	$1.68	1,673	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

On February 6, 2024, the Reporting Person was granted performance-based stock units ("PSUs") under the 2022 Stock Option and Incentive Plan. Each PSU represents the right to receive one share of Common Stock upon vesting. The shares reported were issued to the Reporting Person upon achievement of a performance condition on February 24, 2025, as determined by the Compensation Committee of the Company's Board of Directors.
Represents shares automatically sold by the Company on behalf of the Reporting Person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of the PSUs reported in this form. The mandatory sale of the Reporting Person's shares was provided for in a PSU agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.